Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

PYTEST

UREA, C-14

Standard Dose
1uCi
Max Dose
Refer to approved labeling
Primary Use
Review priority: N/A Marketing status: Discontinued
Summary

Approval overview PYTEST is listed in Drugs@FDA under application 020617 (NDA).

Review priority: N/A Marketing status: Discontinued Active ingredient UREA, C-14 Form and strength CAPSULE;ORAL - 1uCi Sponsor AVENT Submission history Latest submission status date: 2014-01-31 00:00:00.

Structured Monograph

Clinical summary

Approval overview PYTEST is listed in Drugs@FDA under application 020617 (NDA). Review priority: N/A Marketing status: Discontinued Active ingredient UREA, C-14 Form and strength CAPSULE;ORAL - 1uCi Sponsor AVENT Submission history Latest submission status date: 2014-01-31 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: N/A

Interaction Notes

  • No interaction notes stored yet.